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 Though TSH remains the most commonly used endocrine test in clinical practice, the issue of an appropriate TSH, 
and to a lesser extent, free T4 and free T3 reference ranges is still under debate. First of all the distribution of TSH 
reference range is not normal, with median values (also depending on population iodine intake) usually between 
1-1.5 mU/L [1–3]. On the other hand, upper TSH reference limit is (assay-dependent) usually around 4.2-4.5 
mU/L. There is also an argument that significant number of patients (up to 30%) with TSH above 3.0 mU/L have 
an occult autoimmune thyroid disease [4]. On the other hand the upper normal TSH reference range in elderly 
subjects (i.e. 70 plus years) may extend up to around 6.0 mU/L, with relative small changes in free hormones. This 
phenomenon also applies to elderly patients, where autoimmune thyroid disease had been ruled out [1, 2]. 
Furthermore, there is little evidence of any adverse effects of autoimmune thyroid disease in the elderly in the 
absence of an overt hypothyroidism. Indeed, Wang et al [5] surprisingly demonstrated decreased frailty in elderly 
subjects with raised titres of thyroid autoantibodies. It is also well known that in the setting of subclinical 
hypothyroidism, concentrations of free T4 start to decline below 10 pmol/L only with TSH above 6-7 mU/L in 
elderly subjects, though a decline in free T4 is more pronounced in the young (particularly in those aged 20-29 
years), where free T4 starts to decline for TSH concentrations above 4.5 mU/l [6]. Another issue pertains to the risk 
of cardiovascular disease in subjects with subclinical hypothyroidism. There are data from post-menopausal 
women enrolled into the Women Health Initiative study, where an increase in the risk of myocardial infarction was 
demonstrated only for TSH concentrations above 7.0 mU/L [7]. 
A separate issue, extensively discussed elsewhere [8], pertains to alterations of TSH and free thyroid hormones 
during pregnancy. In particular there is decrease in TSH in the first trimester followed by a gradual return to 
pre-pregnancy values. In contrast, there is an increase in free T4 in the first trimester, while in the third trimester 
free T4 concentrations are usually at the lower end of the standard (i.e. pre-pregnancy) reference range, or even just 
below the lower reference limit. Hence, there is an urgent need (postulated in the Endocrine Society Guidelines 
[8]) to create separate reference ranges for TSH and free thyroid hormones during pregnancy, possible with 
reference to each trimester. There are also recent data from China [9], where the authors demonstrated that the 





 week of gestation. The authors of this study suggest that standard reference ranges for TSH and free T4 can 
be applied up to this point of gestation. 
References 
1.  Fontes R, Coeli CR, Aguiar F, Vaisman M: Reference interval of thyroid stimulating hormone and free 
thyroxine in a reference population over 60 years old and in very old subjects (over 80 years): comparison to 
young subjects. Thyroid Res 2013,6(1):13. 10.1186/1756-6614-6-13 
2.  Vadiveloo T, Donnan PT, Murphy MJ, Leese GP: Age- and Gender-Specific TSH Reference Intervals in 
People With No Obvious Thyroid Disease in Tayside, Scotland: The Thyroid Epidemiology, Audit, and 
Research Study (TEARS). J Clin Endocrinol Metab 2013,98(3):1147–1153. 10.1210/jc.2012-3191 
3.  Biondi B: The Normal TSH Reference Range: What Has Changed in the Last Decade? J Clin Endocrinol 
Metab 2013,98(9):3584–3587. 10.1210/jc.2013-2760 
4.  Spencer CA, Hollowell JG, Kazarosyan M, Braverman LE: National Health and Nutrition Examination 
Survey III: Thyroid-Stimulating Hormone (TSH)-Thyroperoxidase Antibody Relationships Demonstrate 
That TSH Upper Reference Limits May Be Skewed by Occult Thyroid Dysfunction. J Clin Endocrinol Metab 
2007,92(11):4236–4240. 10.1210/jc.2007-0287 
5.  Wang GC, Talor MV, Rose NR, Cappola AR, Chiou RB, Weiss C, et al.: Thyroid autoantibodies are 
associated with a reduced prevalence of frailty in community-dwelling older women. J Clin Endocrinol Metab 
2010,95(3):1161–1168. 10.1210/jc.2009-1991 
6.  Hadlow NC, Rothacker KM, Wardrop R, Brown SJ, Lim EM, Walsh JP: The Relationship Between TSH and 
Free T4 in a Large Population Is Complex and Nonlinear and Differs by Age and Sex. J Clin Endocrinol 
Metab 2013,98(7):2936–2943. 10.1210/jc.2012-4223 
7.  LeGrys VA, Funk MJ, Lorenz CE, Giri A, Jackson RD, Manson JE, Schectman R, Edwards TL, Heiss G, 
Hartmann KE: Subclinical Hypothyroidism and Risk for Incident Myocardial Infarction Among 
Postmenopausal Women. J Clin Endocrinol Metab 2013,98(6):2308–2317. 10.1210/jc.2012-4065 
8.  De Groot L, Abalovich M, Alexander EK, Amino N, Barbour L, Cobin RH, et al.: Management of Thyroid 
Dysfunction during Pregnancy and Postpartum: An Endocrine Society Clinical Practice Guideline. J Clin 
Endocrinol Metab 2012,97(8):2543–2565. 10.1210/jc.2011-2803 
9.  Li C, Shan Z, Mao J, Wang W, Xie X, Zhou W, et al.: Assessment of Thyroid Function During First- 
Trimester Pregnancy: What Is the Rational Upper Limit of Serum TSH During the First Trimester in 
Chinese Pregnant Women? J Clin Endocrinol Metab 2014,99(1):73–79. 10.1210/jc.2013-1674 
